Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Surya Citra Media Tbk. (SCMA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Surya Citra Media Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Surya Citra Media Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Surya Citra Media Tbk. trades at Rp210 (market cap 15.09T, 31.1M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Surya Citra Media Tbk. is the larger of the two by market cap, and Surya Citra Media Tbk. is more actively traded (31.1M versus 429.7K). Which is the better fit depends on your goals.

SCMATSPC
Market Cap
15.09T11.68T
Volume
31.1M429.7K
Lot
311K4.3K
Turnover
6.45B1.11B
Average Price
207.522,591.65
Value
6.45B1.11B
Indicative Equilibrium Price
2102,580
Indicative Equilibrium Volume
13.37K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCMA
View details
TSPC
View details

About Surya Citra Media Tbk.

PT Surya Citra Media Tbk (the Company) formerly PT. Surya Citra Televisi, or popularly known as SCTV, started operations in Surabaya the capital of East Java in 1990 as a regional television station to server the province and the island of Bali. In 1993, pursuant to moving its headquarters to Jakarta, SCTV began broadcasting nationwide. In 29 Jan 1999 PT Cipta Aneka Selaras was established at jakarta and the company changed to PT Surya Citra Media at 31 Dec 2001. PT Elang Mahkota Teknologi Tbk is the ultimate parent company of the Company and Subsidiaries.

Read more on SCMA

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC